Page 7 - Diabetes

Over 11.4% Indians diabetic, 35.5% suffer from hypertension: Lancet journal

The prevalence of diabetes in India is 11.4 per cent, while 35.5 per cent of people suffer from hypertension, according to the findings of a nationwide survey published in The Lancet Diabetes & Endocrinology journal. The study, conducted by the Madras Diabetes Research Foundation in collaboration with the Indian Council of Medical Research (ICMR) and other institutes, also found that the prevalence of generalised obesity and abdominal obesity in India stood at 28.6 and 39.5 per cent, respectively. The results, assessing the burden of non-communicable diseases (NCD) across the states, are based on a survey of 1,13,043 (over 1.1akh) people (33,537 urban and 79,506 rural residents), in 31 states and Union Territories in the country, between 2008 and 2020. The survey also showed that 35.5 per cent of Indians suffer from hypertension, 15.3 per cent of people have pre-diabetes, while an alarming 81.2 per cent have dyslipidaemia -- the imbalance of lipids such as cholesterol, low-density

India ready to lead technology-driven diabetes care, says Jitendra Singh

Union minister Jitendra Singh on Sunday said India is fast becoming a huge medical tourism hub and it is ready to lead technology-driven diabetes care. Addressing the three-day World Congress of 'Diabetes Technology and Therapeutics 2023' (DTechCon 2023) here, he said the country is being looked up to by the rest of the world in the field of healthcare after the successful handling of the COVID-19 pandemic. "Technologically and in human resources, we are much ahead of most other countries," said Singh, the Minister of State for Personnel. He said India is not only becoming a technology leader, but also a huge medical tourism hub. "India is ready to lead technology-driven diabetes care," said Singh, who is also a renowned diabetologist. He said India is in the frontline of diabetes research in the world and the prevention of diabetes is not only "our duty towards healthcare, but also our duty towards nation building because this is a country with 70 per cent population below the ag

Study claims childhood trauma can lead to develop type 2 diabetes later

The study aimed to determine whether there was a link between childhood adversity and the development of T2D in early adulthood (16-38 years) among men and women

Approx 1 person in 20 is diabetic, 3-5% of new cases linked to Covid: Study

The findings, published in JAMA Network Open, showed that men were more likely to develop diabetes than women

Poor diet linked to 14 million cases of type 2 diabetes globally: Study

Poor diet contributed to over 14.1 million cases of type 2 2 diabetes in 2018, representing over 70 per cent of new diagnoses globally, according to a study. Of the 30 most populated countries studied, India, Nigeria, and Ethiopia had the fewest case of type 2 diabetes related to unhealthy eating, the researchers said. The analysis, published in the journal Nature Medicine, looked at data from 1990 and 2018, providing valuable insight into which dietary factors are driving type 2 diabetes burden by world region. The researchers found that Of the 11 dietary factors considered, three had an outsized contribution to the rising global incidence of type 2 diabetes: Insufficient intake of whole grains, excesses of refined rice and wheat, and the overconsumption of processed meat. Factors such as drinking too much fruit juice and not eating enough non-starchy vegetables, nuts, or seeds, had less of an impact on new cases of the disease, they said. "Our study suggests poor carbohydrate ..

Union Minister Jitendra Singh bats for prevention of diabetes in pregnancy

Union Minister Jitendra Singh Friday made a strong pitch for the prevention of diabetes in pregnancy to prevent the passing of the health condition to future generations. Addressing the annual conference of Diabetes in Pregnancy Study Group of India (DIPSI), Singh said type-2 diabetes has already assumed epidemic proportions in the country which has achieved the dubious distinction of being the 'diabetes capital' of the world. "In an alarming situation like this, unless we can effectively prevent the occurrence of diabetes in pregnant women, it may not be possible to break the chain of Type-2 Diabetes Mellitus getting passed from generation to generation and thus affecting the future generations," he said. Singh, a diabetologist, said a woman affected by gestational diabetes mellitus (GDM) is likely to pass on to her progeny a higher preponderance to develop type-2 diabetes and that too at a relatively younger age. Singh, a founder member of DIPSI, had a special word of appreciatio

Apple Watch blood glucose monitor could revolutionise diabetes care

If perfected, such a breakthrough would be a boon to diabetics and help cement Apple as a powerhouse in health care

Researchers reveal Covid-19 infection increases diabetes, disease risk

This research, Kwan says, is one piece of the puzzle that will help researchers understand how to prevent metabolic as well as cardiovascular disease risk in the future

Drug firm Glenmark gets USFDA nod for generic diabetes drug to market in US

Drug firm Glenmark said it has received approval from the US health regulator to market a generic medication to treat diabetes in the American market. Glenmark Pharmaceuticals Inc, USA, a unit of the company, has received tentative approval from the US Food & Drug Administration (US FDA) for Saxagliptin Tablets in strengths of 2.5 mg and 5 mg, the Mumbai-based drug maker said in a statement. The company's product is the generic version of AstraZeneca AB's Onglyza tablets (2.5 mg and 5 mg), it added. According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza tablets (2.5 mg and 5 mg) achieved annual sales of around USD 122.3 million. Glenmark said its current portfolio consists of 179 products authorised for distribution in the US marketplace. The drug firm has 46 abbreviated new drug applications (ANDAs) pending approval with the USFDA, it added. In addition to these internal filings, Glenmark continues to identify and explore external development ...

Covid's omicron variant, thought to be milder, can increase diabetes risk

Omicron has been seen as a milder version of Covid compared with earlier strains, leading to lower rates of hospitalization and death than delta and the strain that first emerged from China

Best Natural Treatment For Diabetes: Home Remedies For Type 2 Diabetes

.

Cut down on sugar

Multiple levers are available to improve public health

Glenmark Pharma launches combination drug for Type 2 diabetic patients

Glenmark Pharmaceuticals Ltd on Wednesday said it has launched triple fixed-dose combination Teneligliptin with Pioglitazone and Metformin in India for diabetic patients. This fixed-dose combination offers patients with Type 2 diabetes the convenience of once daily dosing to improve their glycemic control. It is priced at Rs 14.90 per day, thereby reducing the daily cost of therapy by 40 per cent, making it more affordable to the masses, the company said in a statement. It has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, it added. "Type 2 diabetes patients in India often face issues of beta cell dysfunction along with insulin resistance. In fact, the prevalence of high insulin resistance in India is 38 per cent compared to the global incidence of 15 per cent," Glenmark Pharmaceuticals EVP & Business Head - India Formulations Alok Malik said. The market .

Torrent Pharma, Boehringer Ingelheim India to co-market diabetes drug

Torrent Pharmaceuticals on Wednesday said it has inked a pact with Boehringer Ingelheim India to co-market diabetes drug and its combinations in the country. The company has inked an agreement to jointly sell Cospiaq (Empagliflozin), Cospiaq Met (Empagliflozin+ Metformin) and Xilingio (Empagliflozin+ Linagliptin). Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus. It is also indicated to reduce the risk of cardiovascular death, in adults with type 2 diabetes mellitus and established cardiovascular disease. "I am confident that the launch of Cospiaq, Cospiaq Met and Xilingio will further strengthen our overall diabetes and cardiovascular portfolios and bolster our position as a leading player in these high growth segments within the Indian pharmaceutical market," Torrent Pharmaceuticals Director Aman Mehta said in a statement. Boehringer Ingelheim India Managing Direct

Artificial intelligence can be helpful in diabetes monitoring, prevention

Artificial intelligence can be used to turn a continuous glucose monitor (CGM) into a potent tool for diabetes monitoring and prevention, suggests researchers at Klick Applied Sciences

AstraZeneca India gets regulator's approval to market anti-diabetes drug

Drug firm AstraZeneca India on Tuesday said it has received approval from the country's drug regulator to market anti-diabetes medication Dapagliflozin. The company said it has received approval from the Central Drugs Standard Control Organization (CDCSCO) for the drug indicated for diabetes patients with chronic kidney disease (CKD). Dapagliflozin is the first and only anti-diabetic drug approved to significantly reduce the risk of sustained eGFR (estimated Glomerular Filtration Rate), cardiovascular deaths and hospitalisations due to heart failure in adults with progressive chronic kidney disease, the drug firm said. The approval is applicable for both diabetic and non-diabetic CKD patients, it added. CKD is one of the leading causes of hospitalisation globally and in India, representing a significant clinical and economic burden. "The timely approval of Dapagliflozin from the CDCSCO committee with the additional indication is a huge boost for nephrologists across the country .

Type 2 diabetes linked with gestational diabetes in S Asian women: Study

Women of South Asian origin may be more likely to experience gestational diabetes due to the same complex genetics that increases their chance of acquiring type 2 diabetes, according to a study

Covid can deteriorate diabetes, associated heath disease: Scientist

Covid can alter a person's genetic makeup which can enhance the proliferation of disease and cause further deterioration in diabetes and associated heart disease, an Indian-origin researcher revealed

IRCTC allowed to customise menu for diabetics, infants, health aficionados

The Railway Board has given its catering and tourism arm IRCTC the flexibility to customise its menu to include local and regional cuisines as well as food suitable for diabetics, infants and health aficionados. According to a note sent by the Railway Board to the Indian Railway Catering and Tourism Corporation (IRCTC), the move is aimed at improving catering services on trains and give passengers more options. "As a measure to improve catering services on trains, it has been decided to give IRCTC the flexibility to customize the menu so as to include items of regional cuisines/preferences, seasonal delicacies, requirement during festivals, food items as per the preferences of different group of passengers such as diabetic food, baby food, health food options, including millet-based local products among others," the note said. At present, the IRCTC has to get the menus, comprising mostly of standardised food items and beverages, approved by the Railway Board before it can introduce

World Health Organization calls for increased access to diabetes education

The WHO on Monday called for increased access to quality diabetes education for healthcare workers, the public and people living with diabetes as part of efforts to ensure better access to quality and affordable care for the disease. Globally, around 422 million people have diabetes, and 1.5 million deaths are directly attributed to diabetes every year, Dr Poonam Khetrapal Singh, WHO Regional Director for South-East Asia, said on the World Diabetes Day. In the WHO South-East Asia Region, more than 96 million people are estimated to have diabetes, and another 96 million to be pre-diabetic, causing at least 600,000 deaths annually, she said. "By 2045, unless urgent action is taken, the prevalence of diabetes in the region is expected to increase by 68 per cent," Singh said in a statement. Diabetes is a chronic metabolic disease. If detected late or improperly managed, it can lead to serious and life-threatening damage to the heart, blood vessels, eyes, kidneys and nerves. The risk o